Blogs
Peter
http://spaces.msn.com/medizine
Dr. Peter Hofland (PhD) is COO/General Manager (North America) at GCV Capital, LLC. Together with his team of market specialists he manages various private venture capital partnership funds for individual and institutional investors.
Before joining GCV Capital he was a VP/Senior Consultant and member of the management team of The Visual Consultancy Corporation, an international medical/pharmaceutical consulting and communication firm.
As a medical & pharmaceutical marketing and communication expert Peter has more than twelve years of management consulting experience, with special emphasis on analytical research, medical marketing & communications and project management. He has consulted for some of the largest pharmaceutical companies in the world and many biotech companies, including Pfizer, Roche and Novartis, Amgen and Genzyme.
With The Visual Consultancy Corporation, he managed several projects including the following:
·International brand development and product launch of various drugs;
·Development and design of Medical Smart Card Projects for Clinical Research;
·Set-up and co-manage a Clinical Research (Drug development)company in France;
·Development of marketing, public relation and communication strategies.
Prior to The Visual Consultancy Corporation, he served as a member of the management team of Qumulus N.V. a Netherlands Antillean company specializing in medical information technology, medical e-learning and corporate communication. He was responsible for strategic and tactical development of the IT and healthcare communications. He developed strategic growth plans as well as managed several projects to operationalize the plan, among other things.
Peter has a thorough understanding of both the European and American business cultures and he has utilized that effectively in delivering significant value to his clients.
He holds a PhD in Medical Sciences, as well as various post-graduate certificates in project management, pharmaceutical innovation and strategic pharmaceutical, among others. He is fluent in English and Dutch.
